Sumitomo Mitsui Financial Group, Inc. (LON:0LAF)
London
· Delayed Price · Currency is GBP · Price in USD 18.54
-0.28 (-1.48%)
At close: Dec 3, 2025
LON:0LAF Revenue
Sumitomo Mitsui Financial Group had revenue of 1.61T JPY in the quarter ending September 30, 2025, with 5.08% growth. This brings the company's revenue in the last twelve months to 3.42T, down -17.54% year-over-year. In the fiscal year ending March 31, 2025, Sumitomo Mitsui Financial Group had annual revenue of 3.27T, down -7.74%.
Revenue (ttm)
3,424.32B JPY
Revenue Growth
-17.54%
P/S Ratio
5.33
Revenue / Employee
27.84M JPY
Employees
123,000
Market Cap
91.77B GBP
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3,274.69B | -274.54B | -7.74% |
| Mar 31, 2024 | 3,549.22B | -18.19B | -0.51% |
| Mar 31, 2023 | 3,567.41B | 756.55B | 26.92% |
| Mar 31, 2022 | 2,810.87B | -54.89B | -1.92% |
| Mar 31, 2021 | 2,865.75B | 620.60B | 27.64% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Shell | 200.18B |
| Unilever | 51.24B |
| British American Tobacco p.l.c. | 25.60B |
| Rio Tinto Group | 39.22B |
| Rolls-Royce Holdings | 19.54B |
| GSK plc | 32.17B |